enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Editas Medicine - Wikipedia

   en.wikipedia.org/wiki/Editas_Medicine

   Editas Medicine was originally founded with the name "Gengine, Inc." in September 2013 by Feng Zhang of the Broad Institute, Jennifer Doudna of the University of California, Berkeley, [7] and George Church, David Liu, and J. Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures; the name was changed to the current "Editas Medicine" two ...

3. Editas (EDIT) Up More Than 100% in Past 3 Months: Here ... - AOL

   www.aol.com/news/editas-edit-more-100-past...

   Editas' (EDIT) lead candidate EDIT-101, that employs CRISPR gene editing to treat LCA10, holds potential. The company is also developing EDIT-301 for treating SCD. Editas (EDIT) Up More Than 100% ...

4. Editas Medicine Stock History: The Story Behind the ... - AOL

   www.aol.com/news/editas-medicine-stock-history...

   Here's the story behind the biotech stock that could be the best way to profit from the discovery of the century: CRISPR-Cas9 gene editing.

5. Google Patents - Wikipedia, the free encyclopedia

   en.wikipedia.org/wiki/Google_Patents

   Wikipedia entry for Google Patents.Google Patents is a search engine from Google that indexes patents and patent applications from the United States Patent and Trademark Office.

6. James Mullen (CEO) - Wikipedia

   en.wikipedia.org/wiki/James_Mullen_(CEO)

   James C. “Jim” Mullen (born ca. 1958) is an American business executive. He is the executive chairman at genome editing company Editas Medicine since 2018, where he also served as CEO between 2021 and 2022.

7. AOL

   search.aol.com

   The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web. AOL.

8. Editas, Allergan Start Dosing in Early-Stage Eye Disease Study

   www.aol.com/news/editas-allergan-start-dosing...

   Editas (EDIT) and Allergan are co-developing a CRISPR-based candidate, AGN-151587, for treating Leber congenital amaurosis 10 (LCA10), an inherited form of blindness. Editas, Allergan Start Dosing ...

9. List of pharmaceutical companies - Wikipedia

   en.wikipedia.org/wiki/List_of_pharmaceutical...

   This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.